ClinicalTrials.gov
public full text
Public Domain
Imaging a Cholinergic Biomarker of Cognition in Parkinson's Disease
This is an imaging study designed to illuminate the function of the cholinergic system and its association with cognitive skills in people with Parkinson's disease. The hypothesis of this study is that there will be an association between cholinergic terminal density, sex hormones, and cognitive functioning. Participants will receive a PET and MRI scan along with a battery of neurocognitive tests at baseline and again at 18 months follow-up. Hormone levels will be measured at baseline.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Executive, Activities of Daily Living, and Cholinergic Functions in Parkinson's Disease#865329
- Comprehensive evaluation of AT(N) imaging biomarkers for predicting cognitive decline.#1091150
- Single Photon Emission Computed Tomography to Study Receptors in Parkinson's Disease#1104158
- Striatal and Extra-striatal Mechanisms of Falling in Parkinson's Disease#1032833
- Investigating the Role of Serotonin in Emotional Processing Through the Use of Tryptophan Depletion#1230488
Record · ID 1195965
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive